155 related articles for article (PubMed ID: 7675447)
1. Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
McIntosh GG; Anderson JJ; Milton I; Steward M; Parr AH; Thomas MD; Henry JA; Angus B; Lennard TW; Horne CH
Oncogene; 1995 Sep; 11(5):885-91. PubMed ID: 7675447
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
Nielsen NH; Emdin SO; Cajander J; Landberg G
Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
[TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
Gillett C; Fantl V; Smith R; Fisher C; Bartek J; Dickson C; Barnes D; Peters G
Cancer Res; 1994 Apr; 54(7):1812-7. PubMed ID: 8137296
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
Bartkova J; Lukas J; Strauss M; Bartek J
J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
[TBL] [Abstract][Full Text] [Related]
6. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
9. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
van Diest PJ; Michalides RJ; Jannink L; van der Valk P; Peterse HL; de Jong JS; Meijer CJ; Baak JP
Am J Pathol; 1997 Feb; 150(2):705-11. PubMed ID: 9033283
[TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
[TBL] [Abstract][Full Text] [Related]
12. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
13. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth.
Han EK; Sgambato A; Jiang W; Zhang YJ; Santella RM; Doki Y; Cacace AM; Schieren I; Weinstein IB
Oncogene; 1995 Mar; 10(5):953-61. PubMed ID: 7898937
[TBL] [Abstract][Full Text] [Related]
14. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
[TBL] [Abstract][Full Text] [Related]
15. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1995 Feb; 10(4):775-8. PubMed ID: 7862456
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.
Russell A; Thompson MA; Hendley J; Trute L; Armes J; Germain D
Oncogene; 1999 Mar; 18(11):1983-91. PubMed ID: 10208420
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
Weroha SJ; Li SA; Tawfik O; Li JJ
Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
[TBL] [Abstract][Full Text] [Related]
19. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
